Solid report and like the two new partnerships signed. Cost...

Solid report and like the two new partnerships signed. Cost effective way of entering new markets. On track for $30M sales orders for FY22 so next quarter will be a similar number. Share price should start basing around the 70 cent mark although it's a pretty ugly market for growth/tech stocks at the moment. In respect of inflation I think M7T ticks the boxes for a stock to hold. No cost pressures from inputs and a sticky product offering. They have already covered off on salary increases to retain and bed down talent in the last report.